Integrin v&bgr;3 Antagonists for Anti-Angiogenic Cancer Treatment

E-ISSN： 2212-3970|2|2|143-158

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.2, Iss.2, 2007-06, pp. : 143-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Angiogenic Cancer Therapy Based on Integrin v&bgr;3 Antagonism

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 6, Iss. 5, 2006-09 ,pp. : 407-428

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Angiogenic Therapy as a Cancer Treatment Paradigm

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 2, 2005-03 ,pp. : 115-130

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-angiogenic active immunotherapy: a new approach to cancer treatment

By Pan Jianping Jin Pengfeng Yan Jie Kabelitz Dieter

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 8, 2008-08 ,pp. : 1105-1114

Springer Publishing Company

Access to resources Recommend Favorite

Anti-Angiogenic Treatment of Gastrointestinal Malignancies

By Salmon J. Lockhart A. Berlin Jordan

Cancer Investigation, Vol. 23, Iss. 8, 2005-11 ,pp. : 712-726

Informa Healthcare

Access to resources Recommend Favorite

Anti-Angiogenic Agents in Pancreatic Cancer: A Review

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 5, 2011-01 ,pp. : 464-469

Bentham Science Publishers

Access to resources Recommend Favorite